BDX vs WST
BDX: BD is a leading global medical technology company providing essential medical devices, diagnostic systems, and laboratory solutions to healthcare providers and researchers worldwide. WST: West Pharmaceutical Services provides essential high-quality, sterile packaging and delivery systems for injectable medications globally.
Side-by-side fundamentals
| Metric | BDX | WST | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $152.97 | $355.48 | |
| Market cap as of 2026-07-24 | $42.2B | $25.7B | |
| P/E as of 2026-07-24 | 37.07 | 47.44 | BDX lower |
| PEG as of 2026-07-24 | -20.92 | 3.24 | BDX lower |
| Net margin as of 2026-07-24 | +5.3% | +16.9% | WST higher |
| Gross margin as of 2026-07-24 | +47.0% | +36.3% | BDX higher |
| Operating margin as of 2026-07-24 | +10.2% | +20.3% | WST higher |
| ROE as of 2026-07-24 | +4.5% | +17.9% | WST higher |
| ROA as of 2026-07-24 | +2.1% | +13.2% | WST higher |
| Debt / equity as of 2026-07-24 | 0.72 | 0.07 | WST lower |
| Revenue growth (YoY) as of 2026-07-24 | +2.4% | +11.2% | WST higher |
| Revenue CAGR (3y) SEC XBRL | +5.0% | +2.1% | BDX higher |
| Dividend yield as of 2026-07-24 | +2.7% | +0.3% | BDX higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-07-24 | 0.21 | 1.12 | |
| 1-year return as of 2026-07-23 close | +6.6% | +56.4% | WST higher |
Fundamentals: Finnhub, as of 2026-07-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.